Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Sep;20(6):526-35.
doi: 10.1038/jes.2009.41. Epub 2009 Aug 26.

Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling

Affiliations
Comparative Study

Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling

Zheng Li et al. J Expo Sci Environ Epidemiol. 2010 Sep.

Erratum in

Abstract

Urinary mono-hydroxy polycyclic aromatic hydrocarbons (OH-PAHs) are commonly used in biomonitoring to assess exposure to polycyclic aromatic hydrocarbons (PAHs). Similar to other biologically non-persistent chemicals, OH-PAHs have relatively short biological half-lives (4.4-35 h). Little information is available on their variability in urinary concentrations over time in non-occupationally exposed subjects. This study was designed to (i) examine the variability of nine urinary OH-PAH metabolite concentrations over time and (ii) calculate sample size requirements for future epidemiological studies on the basis of spot urine, first-morning void, and 24-h void sampling. Individual urine samples (n=427) were collected during 1 week from 8 non-occupationally exposed adults. We recorded the time and volume of each urine excretion, dietary details, and driving activities of the participants. Within subjects, the coefficients of variation (CVs) for the wet-weight concentration of OH-PAHs in all samples ranged from 45% to 297%; creatinine adjustment reduced the CV to 19-288% (P<0.001; paired t-test). The simulated 24-h void concentrations were the least variable measure, with CVs ranging from 13% to 182% for the 9 OH-PAHs. Within-day variability contributed on average 84%, and between-day variability accounted for 16% of the total variance of 1-hydroxypyrene (1-PYR). Intraclass correlation coefficients of 1-PYR levels were 0.55 for spot urine samples, 0.65 [corrected] for first-morning voids, and 0.77 [corrected] for 24-h voids, indicating a high degree of correlation between urine measurements collected from the same subject over time. Sample size calculations were performed to estimate the number of subjects required for detecting differences in the geometric mean at a statistical power of 80% for spot urine, first-morning, and 24-h void sampling. These data will aid in the design of future studies of PAHs and possibly other biologically non-persistent chemicals and in the interpretation of their analytical results.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Wet weight (A) and creatinine-adjusted (B) concentrations of 1-hydroxypyrene in all individual urine samples from 8 subjects (S1–S8) during 7 days.
Figure 2
Figure 2
Levels of 1-hydroxypyrene in Subject 5 during one week for wet weight (A) and creatinine-adjusted concentrations (B).
Figure 3
Figure 3
Normalized creatinine-adjusted concentrations of 4 OH-PAH metabolites for Subject 8 during 7 days. The subject consumed barbecue chicken for lunch on Thursday.
Figure 4
Figure 4
Contribution of between- and within-subject (A), between- and within-day (B) effects to total variance for 4 urinary OH-PAH metabolites.

Similar articles

Cited by

References

    1. ATSDR. Toxicological Profile for Polycyclic Aromatic Hydrocarbons. Atlanta: Agency for Toxic Substances and Disease Registry; 1995. [[accessed October 1, 2008]]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp69.html. - PubMed
    1. Barr DB, Wilder LC, Caudill SP, Gonzales AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113:192–200. - PMC - PubMed
    1. Boogaard PJ, van Sittert NJ. Exposure to polycyclic aromatic hydrocarbons in petrochemical industries by measurement of urinary 1-hydroxypyrene. Occup Environ Med. 1994;51:250–258. - PMC - PubMed
    1. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect. 2002;110(Suppl 3):451–488. - PMC - PubMed
    1. Brzeznicki S, Jakubowski M, Czerski B. Elimination of 1-hydroxypyrene after human volunteer exposure to polycyclic aromatic hydrocarbons. Int Arch Occup Environ Health. 1997;70:257–260. - PubMed

Publication types

Substances